FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Akorn Gabapentin Oral Solution Recall

Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per…

Akorn, Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Mar 24, 2021
Recall ID
D-0301-2021
Check your lot numberHow we source this data

Summary

Akorn recalled Gabapentin Oral Solution starting Mar 8, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0301-2021 on Mar 24, 2021. Reason: Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing

Product description

Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per tray, For Institutional Use Only, Rx only, Hi-Tech Pharmacal Co., Inc, Amityville, NY 11701, NDC Tray: 50383-311-07; NDC Unit Dose Cup 50383-311-07

Lot numbers, UPCs & expiration codes

Lot 369409, Exp. Date 05/2021; Lot 372393, Exp. Date 01/2022; Lot 373112, Exp. Date 04/2022

Where it was sold

Nationwide USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0301-2021
Classification
Class II
Status
Terminated
Recall initiated
Mar 8, 2021
FDA report date
Mar 24, 2021
Quantity
8,183 unit dose cups
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn, Inc.

Original FDA data

Every field from FDA enforcement report D-0301-2021, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
87462
Address
1925 W Field Ct Ste 300
Code information
Lot 369409, Exp. Date 05/2021; Lot 372393, Exp. Date 01/2022; Lot 373112, Exp. Date 04/2022
Postal code
60045-4862
Report date
Mar 24, 2021
Product type
Drugs
Recall number
D-0301-2021
Classification
Class II
Recalling firm
Akorn, Inc.
Product quantity
8,183 unit dose cups
Termination date
Aug 9, 2022
Reason for recall
Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing
Voluntary / mandated
Voluntary: Firm initiated
Product description
Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per tray, For Institutional Use Only, Rx only, Hi-Tech Pharmacal Co., Inc, Amityville, NY 11701, NDC Tray: 50383-311-07; NDC Unit Dose Cup 50383-311-07
Distribution pattern
Nationwide USA
Recall initiation date
Mar 8, 2021
Initial firm notification
Letter
Center classification date
Mar 16, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0301-2021, published Mar 24, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls